FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Healthcare & Life Sciences Enterprise Capital Monitor – USA – 07/2024”.
The Monitor is a month-to-month printed overview of enterprise capital tendencies within the US Healthcare & Life Sciences sector.
As of the top of June 2024 we recognized the next present VC tendencies in america:
- Complete Healthcare & Life Sciences funding reached EUR 22,529m
- Biotech acquired 52% of the overall funding quantity (EUR 11,810m) with oncology being the main indication (26%)
- In July Aspect Biosciences secures the best transaction quantity with EUR 258m, adopted by Cardurion with EUR 242m and Beacon Therapeutics with EUR 158m
- ARCH Enterprise Companions (United States) is probably the most lively investor (by deal quantity), adopted by RA Capital Administration (United States) and F-Prime Capital (United States)
To entry the total report, please click on right here.
By Mathias Klozenbücher und Johannes Hyperlink
